RT Journal Article
SR Electronic
T1 Efficacy of face-masks used in Uganda: a laboratory-based inquiry during the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.28.20202952
DO 10.1101/2020.09.28.20202952
A1 Gerald Mboowa
A1 Derrick Semugenze
A1 Hellen Nakabuye
A1 Douglas Bulafu
A1 Dickson Aruhomukama
YR 2020
UL http://medrxiv.org/content/early/2020/09/29/2020.09.28.20202952.abstract
AB Background With shortages of face-masks continuing to be reported worldwide, critical questions like whether or not there is an adequate alternative to commercially manufactured face-masks continue to linger especially in low- and middle-income settings. This study aimed at addressing this through testing and comparing various materials and forms of face-masks for filtration efficiency, breathability, microbial cleanliness, distance-dependent fitness, and re-usability of different face-masks procured from face-mask vendors in Kampala, Uganda.Methods This was a laboratory-based descriptive study that applied new protocols and already existing protocols with substantive modifications to ten different types of face-mask types each in quadruplicate to achieve each specified aim.Results Surgical face-masks had better filtration efficiency, distance-dependent fitness and breathability compared to other face-masks tested. Decontamination of these face-masks with 70% ethanol negatively affected their efficacy. Locally-made double layered face-masks had better: filtration efficiency, distance-dependent fitness and breathability compared to other locally-made cloth face-masks, and re-usability compared to all the face-mask types that had been tested.Discussion/conclusions Locally-made double layered cloth face-masks could serve as alternative face-masks especially for populations in low- and middle-income settings like Uganda while allowing restricted use of surgical face-masks and other respirators like the KN95 to high-risk groups only.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementThis work was supported by the Government of Uganda through Makerere University Research and Innovations Fund (RIF) under the RIF Special COVID-19 Research and Innovation Awards- 2020 (Grant #: MAK/DVCFA/151/20). The views expressed herein are those of the author(s) and not necessarily those of the Government of Uganda and Makerere University Research and Innovations Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approvals were obtained from the: (1) School of Biomedical Sciences-Research and Ethics Committee, College of Health Sciences, Makerere University (approval number: SBS-793) and the Uganda National Council for Science and Technology (approval number: SS489ES). Written informed consent was obtained from each of the study volunteers before performing the laboratory investigations.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.